Publication | Closed Access

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

Molecular PharmacologyHypertensionAntihypertensive AgentsMedicineRenin-angiotensin-aldosterone SystemHypertensive PatientsAntihypertensive TherapyCardiovascular PharmacologyPharmacotherapyEndocrine HypertensionPharmacologyBlood PressureSq 14,225